About Beijing Wantai Biological Pharmacy Enterprise Company

The company was founded in 1991 and is a high-tech enterprise engaged in research and development and production of biological diagnostic reagents and vaccines. The company pursues “contributing to the cause of human health” and is committed to transforming biotechnological achievements into high-quality products to serve the public. A high-tech enterprise engaged in R&D, production and sales of vaccines, in vitro diagnostic reagents and in vitro diagnostic instruments. The main products are two categories: in vitro diagnostic products and vaccine products. Corporate honors: The company won the second prize for HIV third-generation diagnostic reagents and the first prize for scientific and technological progress from the Ministry of Education; “Discovery and clinical application of hepatitis E virus dominant conformational antigen clusters” won the second prize of the National Technological Invention Award and the first prize of Fujian Science and Technology; rapid HIV antibody diagnostic reagents won the Beijing Science and Technology Progress Award; T-lymphocytic leukemia virus antibody reagents won the second prize of the Ministry of Education's Science and Technology Progress Award; “HIV Recombinant Antigens and Series Diagnostic Reagents” was recognized as the “National Torch Program Key Project” Waiting for honors. The products developed by the company won the second prize of the National Science and Technology Progress Award and the second prize of the National Technological Invention Award.